Full Press Release Details
HUMAN HEALTH H u man Pha r mace ut ical H u man N utr ace ut ical ANIMAL HEALTH Animal Pha r mace ut ical Animal N utr ace ut ical 2024 2030 0 500 1000 1500 2000 2024 2034 0 500 1000 1500 2000 MARKET OPPORTUNITY ( HUMAN HEALTH ) The global p ha r mace ut ical ma r ke t Global n utr ace ut ical / supp lemen t ma r ke t $ 1 , 645.7 B $ 591.1 B 6.12 % CAGR 7.6 % CAGR $ 2 , 350.4 B $ 919.1 B So ur ce: G r and Vie w Re s ea r ch .
N . and Lim , E . J . , 2022. Iden t if y ing and add r e ss ing p ill a v e rs ion in ad u l ts w i t ho ut p h ys iological - r ela t ed d ysp hagia : A na rr a t i v e r e v ie w. B r i t i s h Jo ur nal of Clinical Pha r macolog y , 88 ( 12 ), pp.5128 - 5148. ** R u mo r e , M . M . and Vogenbe r g , F . R . , 2016. Bio s imila rs : st ill no t qu i t e r ead y fo r pr ime t ime .
Inc r ea s e p eak concen tr a t ion s The enhanced bioa v ailabili ty and sp eed of ab s o rpt ion pr o v ide s a str ong fo u nda t ion fo r a pp l y ing Gel t e q ' s p la t fo r m ac r o ss m u l t i p le o t he r oil - s ol u ble d ru g cla ss e s and add r e ss ing a ke y ind ustry need Plasma concentration Oil soluble drug in Gelteq gel Oil soluble drug Gelteq Limited 2025.
P r o v ide fa st e r ab s o rpt ion fo r an API Enhance ing r edien t ab s o rpt ion w hich can deli v e r s ignifican t l y im pr o v ed effec t i v ene ss of t he d ru g Inc r ea s e p eak concen tr a t ion s The demon str a t ed bioa v ailabili ty enhancemen ts b y a s ignifican t ma r gin pr o v ide s a str ong fo u nda t ion fo r a pp l y ing Gel t e q ' s p la t fo r m ac r o ss m u l t i p le o t he r w a t e r - s ol u ble d ru g cla ss e s , w i t h t he p o t en t ial t o e xp and t he Com p an y ' s comme r cial s co p e Graph = Gelteq trial results with a water soluble drug and FDA approved product GELTEQ ADVANTAGES - WATER SOLUBLE COMPOUNDS Plasma concentration Water soluble drug in Gelteq gel Water soluble drug with water time post - administration (hours) Gelteq Limited 2025.
Gel t e q ' s p a t en t ed gel deli v e ry can p o t en t iall y syst em s ol v e man y of t he p ha r mace ut ical and supp lemen t ind ustry ' s challenge s - f r om p oo r adhe r ence and p ill fa t ig u e t o t he o r al deli v e ry of in s ol u ble ing r edien ts O ur gel s can incl u de s ingle o r m u l t i p le w a t e r s ol u ble , fine in s ol u ble and oil - s ol u ble ing r edien ts Thi s can incl u de v i t amin s , mic r o and mac r o n utr ien ts , he r bal e xtr ac ts and ac t i v e p ha r mace ut ical ing r edien ts ( API s ), in a s ingle s helf - st able gel w i t h a u nifo r m t e xtur e and com p o s i t ion T r ial r e su l ts s ho w ed Gel t e q ' s inno v a t i v e t echnolog y fo r w a t e r s ol u ble com p o u nd s w a s able t o : Im pr o v e bioa v ailabili ty ( o v e r all ab s o rpt ion ) b y o v e r 40 % .
P . , Pen s on , P . E . , T s e , Y . , Abdelhafi z , M . A . , Ahmed , S . N . and Lim , E . J . , 2022. Iden t if y ing and add r e ss ing p ill a v e rs ion in ad u l ts w i t ho ut p h ys iological - r ela t ed d ysp hagia : A na rr a t i v e r e v ie w. B r i t i s h Jo ur nal of Clinical Pha r macolog y , 88 ( 12 ), pp.5128 - 5148. ** R u mo r e , M .
A global clinical and s cience ba s ed com p an y t ha t ha s de v elo p ed a no v el d ru g deli v e ry p la t fo r m in an inge st ible gel fo r m Gel t e q sp eciali z e s in t he fo r m u la t ion , de v elo p men t and man u fac tur ing of gel pr od u c ts fo r licen s ed p a rt ne rs Fo u nded in 2017 in Melbo ur ne , A ustr alia , t he com p an y eme r ged f r om i ts fo u nde rs ' w o r k a s a die t i t ian , aiming t o im pr o v e p a t ien t com p liance w i t h an ea sy t o sw allo w and enjo y able deli v e ry fo r ma t fo r medica t ion s and n utr i t ional supp lemen ts Gelteq Limited 2025.
Fo r a di s c uss ion of t he s e r i s k s and u nce rt ain t ie s , r efe r t o Gel t e q ' s filing s w i t h t he U . S . Sec ur i t ie s and E x change Commi ss ion (" SEC "), incl u ding i ts Ann u al Re p o rt on Fo r m 20 - F filed on No v embe r 17 , 2025. Gel t e q u nde rt ake s no obliga t ion t o up da t e an y fo rw a r d - looking st a t emen ts t o r eflec t e v en ts o r ci r c u m st ance s af t e r t he da t e he r eof .
All st a t emen ts , o t he r t han st a t emen ts of hi st o r ical fac t , con t ained he r ein a r e fo rw a r d - looking st a t emen ts. Fo rw a r d - looking st a t emen ts in v ol v e kno w n and u nkno w n r i s k s , u nce rt ain t ie s , and o t he r fac t o rs t ha t ma y ca us e ac tu al r e su l ts t o diffe r ma t e r iall y f r om t ho s e e xpr e ss ed o r im p lied in su ch st a t emen ts.